Cardio Diagnostics Inc. (CDIO)
NasdaqCM: CDIO
· Real-Time Price · USD
1.91
-0.08 (-4.02%)
At close: Aug 18, 2026, 3:59 PM
Cardio Diagnostics Inc. (CDIO) Stock Price, Analysis & Data
-4.02% (1D)
| Bid | 1.41 |
| Market Cap | 5.65M |
| Revenue (ttm) | 14.45K |
| Net Income (ttm) | -6.47M |
| Beta | 2.22 |
| EPS (ttm) | -2.77 |
| PE Ratio (ttm) | n/a |
| Forward PE | -7.64 |
| P/B (ttm) | 0.76 |
| P/S (ttm) | 391.18 |
| Earnings Date | Nov 6, 2026 |
| Ask | 2.32 |
| Volume | 47,824 |
| Avg. Volume (20D) | 67,703 |
| Open | 2.00 |
| Previous Close | 1.99 |
| Day's Range | 1.77 - 2.01 |
| 52-Week Range | 0.97 - 7.91 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About CDIO
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platfo...
Industry Biotechnology
Sector Healthcare
IPO Date Jan 14, 2022
Employees 15
Stock Exchange NasdaqCM
Ticker Symbol CDIO
Website https://cdio.ai
Financial Performance
In 2025, Cardio Diagnostics's revenue was 14.82K, a decrease of -57.51% compared to the previous year's 34.89K. Earnings were -6.5M, a decrease of -22.49%.
Financial StatementsEarnings Surprise
Cardio Diagnostics has released their quarterly earnings on May 15, 2025:
Cardio Diagnostics Inc. is scheduled to release its earnings on Nov 6, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
